Evaluation of Wondfo Chlamydia Trachomatis Rapid Diagnostic Cassette Based on Nano-Gold Immunochromatography Gssay（GICA）

Abstract:

This paper explains and demonstrates how to evaluate the sensitivity and specificity of wondfo chlamydia trachomatis rapid diagnostic cassette with GICA for detection of chlamydia trachomatis. 1026 genital specimens were collected from 630 females and 396 males.Two cassettes of wondfo and ClearView were used for the detection of Chlamydia trachomatis samples with blind detection simultaneously, inconsistent results by DFA. Sensitivity, specificity, positive predictive value and negative predictive value of wondfo cassette were analyzed. Out of 1026 samples detected, 83 were positive by both of wondfo and ClearView and 13 showed different results by wondfo and ClearView. Out of the 13 samples, the DFA confirmed 9 were positive. Therefore, 92 samples were truly positive and 934 were truly negative. The sensitivity, specificity, positive predictive value and negative predictive value of wondfo were 96.74% ,99.6% , 95.7% , 99.68%, respectively. The consistent rates of test results of the chlamydia trachomatis rapid diagnostic cassette , wondfo and ClearView, both were the same 98.64%. Of the three standard strains and two clinical strains of dilution test results showed that the sensitivity of wondfo slightly ClearView.The sensitivity and specificity of wondfo for the detection of Chlamydia trachomatis have the accept tability for clinical diagnostic and surveillance data.

• Periodical: Advanced Materials Research (Volumes 236-238)
• Pages: 2436-2440
• DOI: https://doi.org/10.4028/www.scientific.net/AMR.236-238.2436
• Online since: May 2011
• Authors: Yun Ping Peng, Ji Hua Wang, Wen Mei Li, Jun Lin Wu, Shu Juan Yu
• Keywords: Chlamydia trachomatis (CT), Direct Fluorescent Antibody (DFA), GICA, Immunochromatography Assay, Nanogold, Nano-Gold Immunochromatography Assa, Rapid Diagnostic Cassette

References

[1] Mardh PA , Novikova N. Eur J Contracept Reprod Health Care ,2001 ,6 (2) :115- 126.

[2] NCCLS. National Committee for Clinical Laboratory Standards, Wayne, 2000, PA C28-A2, Vol. 20 No 13. 2ed.

[3] Li QL, Xia Liping. Shanghai Journal of Medical Laboratory Sciences，2003，18:31-33.

[4] Huang HF, Shi HJ, Li Q. Chinese Journal of Nosocomiology, 2006 ,16(4) :469 - 470.

[5] Watson DS, Reddy SM, Brahmakshatriya V, et al. J Immunol Methods. 2009 Jan 30; 340(2):123-31.

[6] Yin YP, Peeling RW, Chen XS, et al. Infect, 2006, 82: v33 - 37.

[7] Wang ZY, Cui WG，Zheng YH，et al. The Chinese Journal of Dermatovenereology. 2008, 03:34

[8] Ding JZ, Yu LL, Lou D, et al. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, 2010 Feb, 28(1):30-3

[9] Johnson RE, Green TA, Schachter J, et al. J Clin Microbiol. 2000.12, 38:4382.

[10] Wilbert JN, Robert EJ, Susan D, et al. J ClinMicrobiol, 1999, 37(3): 681 - 685.

[11] Dreses-Werringloer U, Padubrin I, Kohler L, et al.Antimicrob Agents Chemother, 2003, 47(7): 2316-2318.

DOI: 10.1128/aac.47.7.2316-2318.2003

[12] Betsou F, Beaumont K, Sueur JM, et al. J Clin Microbiol, 2003, 41(3): 1274-1276.

[13] Keegan H, Boland C, Malkin A, et al. Cytopathology,2005, 16(2):82-87.

[14] Huo H, Wang QT, Li JM. International Journal of Dermatology and Venereology, 2006，29(11):1039-1040.